Literature DB >> 19860978

Exploring the acceptability and feasibility of conducting a large longitudinal population-based study in Canada.

Susan A Kirkland1, Parminder S Raina, Christina Wolfson, Geoff Strople, Olga Kits, Steven Dukeshire, Camille L Angus, Karen Szala-Meneok, Jennifer Uniat, Homa Keshavarz, Linda Furlini, Amélie Pelletier.   

Abstract

ABSTRACTSuccessful recruitment and retention for population-based longitudinal studies requires understanding facilitators and barriers to participation. This study explored Canadians' views regarding one such study, the proposed Canadian Longitudinal Study on Aging (CLSA). Focus groups of participants > or =40 years of age were held in six proposed CLSA data collection sites (Halifax, Montreal, Hamilton, Winnipeg, Calgary, and Vancouver) to discuss participating in a long-term study of healthy aging. There was fundamental support for longitudinal research on health and aging. Altruism was a key motivation to participation, and universities were viewed as credible parties to conduct such studies. Participants had few worries about providing biological samples but expressed concern about potential misuse of genetic materials, commercialization of participant data, and privacy issues. These findings have already informed current, and will inform future, work on the CLSA, and will also provide useful information to researchers who undertake other population-based longitudinal studies.

Entities:  

Mesh:

Year:  2009        PMID: 19860978     DOI: 10.1017/S0714980809990043

Source DB:  PubMed          Journal:  Can J Aging        ISSN: 0714-9808


  9 in total

1.  Recruitment for genetic studies of epilepsy.

Authors:  Sylwia Misiewicz; Melodie R Winawer
Journal:  Epilepsy Res       Date:  2012-04-02       Impact factor: 3.045

2.  National Children's Study: update in 2010.

Authors:  Steven Hirschfeld; David Songco; Barnett S Kramer; Alan E Guttmacher
Journal:  Mt Sinai J Med       Date:  2011 Jan-Feb

3.  Why do people participate in epidemiological research?

Authors:  Claudia Slegers; Deborah Zion; Deborah Glass; Helen Kelsall; Lin Fritschi; Ngiare Brown; Bebe Loff
Journal:  J Bioeth Inq       Date:  2015-02-12       Impact factor: 1.352

4.  Factors Influencing the Research Participation of Adults with Autism Spectrum Disorders.

Authors:  Kaaren Haas; Debra Costley; Marita Falkmer; Amanda Richdale; Kate Sofronoff; Torbjörn Falkmer
Journal:  J Autism Dev Disord       Date:  2016-05

5.  Giving samples or "getting checked": measuring conflation of observational biospecimen research and clinical care in Latino communities.

Authors:  Sarah Knerr; Rachel M Ceballos
Journal:  BMC Med Ethics       Date:  2015-07-17       Impact factor: 2.652

6.  Genetics and Personal Insurance: the Perspectives of Canadian Cancer Genetic Counselors.

Authors:  Michelle Lane; Ida Ngueng Feze; Yann Joly
Journal:  J Genet Couns       Date:  2015-05-01       Impact factor: 2.537

7.  Life insurance: genomic stratification and risk classification.

Authors:  Yann Joly; Hilary Burton; Bartha Maria Knoppers; Ida Ngueng Feze; Tom Dent; Nora Pashayan; Susmita Chowdhury; William Foulkes; Alison Hall; Pavel Hamet; Nick Kirwan; Angus Macdonald; Jacques Simard; Ine Van Hoyweghen
Journal:  Eur J Hum Genet       Date:  2013-10-16       Impact factor: 4.246

8.  Motives for participating in a web-based nutrition cohort according to sociodemographic, lifestyle, and health characteristics: the NutriNet-Santé cohort study.

Authors:  Caroline Méjean; Fabien Szabo de Edelenyi; Mathilde Touvier; Emmanuelle Kesse-Guyot; Chantal Julia; Valentina A Andreeva; Serge Hercberg
Journal:  J Med Internet Res       Date:  2014-08-07       Impact factor: 5.428

9.  A pilot study to understand feasibility and acceptability of stool and cord blood sample collection for a large-scale longitudinal birth cohort.

Authors:  S R Bailey; C L Townsend; H Dent; C Mallet; E Tsaliki; E M Riley; M Noursadeghi; T D Lawley; A J Rodger; P Brocklehurst; N Field
Journal:  BMC Pregnancy Childbirth       Date:  2017-12-28       Impact factor: 3.007

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.